PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
03-May-2023 Relief Therapeutics Announces Implementation Timeline for Reverse Split of Ordinary Shares Relief Therapeutics Holding SA
03-May-2023 Gastrointestinal Stent Market is likely to display growth at a CAGR of 5.5% from 2023 to 2033 | Get Insights FMI MARKITWIRED
03-May-2023 3D Bioprinting Market is holding a valuation of US$ 2 billion as of 2023 | FMI MARKITWIRED
03-May-2023 Fiducial Markers Market to reach a valuation of ~US$ 408.3 Million by the year 2033 | Says Future Market Insights MARKITWIRED
03-May-2023 Physiotherapy Equipment Market is estimated to capture a valuation of US$ 20,367.16 million in 2023 and US$ 38,134.8 million in 2033 MARKITWIRED
03-May-2023 Electrophysiology Market is expected to be worth US$ 7.57 billion in 2023 | Get Insights FMI MARKITWIRED
02-May-2023 ISS Joins Glass Lewis in Recommending Aurinia Shareholders Vote “FOR” ALL Company Director Nominees at 2023 Annual General Meeting Businesswire
02-May-2023 Russell Budd Recognized as 2023 Trailblazers Plaintiffs’ Lawyer by the National Law Journal Businesswire
02-May-2023 Vesigen Therapeutics Announces Presentations at the American Society of Gene and Cell Therapy 26th Annual Meeting Businesswire
02-May-2023 EdiGene to Unveil Promising Preclinical POC Data for LEAPER™ 2.0-based in vivo RNA Editing Therapies in NHP Model at the 26th Annual Meeting of ASGCT via Oral Presentation Businesswire
02-May-2023 ENDRA Life Sciences Announces Closing of Public Offering and Full Exercise of Underwriter’s Option to Purchase Additional Securities Businesswire
02-May-2023 Enanta Pharmaceuticals to Host Conference Call on May 8 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2023 Businesswire
02-May-2023 Publix Pharmacy wins Retail Specialty Pharmacy Patient Choice Award Businesswire
02-May-2023 Medical Robotic System Market Will Reach USD 36.25 Billion by 2029 The Wire Times
02-May-2023 APONTIS PHARMA AG adjusts forecast for fiscal year 2023 APONTIS PHARMA AG
02-May-2023 Aurinia Pharmaceuticals Announces Swissmedic Approval of LUPKYNIS® (voclosporin) Businesswire
02-May-2023 SpotSee Acquires Marathon Products Businesswire
02-May-2023 AscellaHealth Captures Two Stevie Awards, Recognized as Fastest Growing Company and Marketing Department of the Year by 2023 American Business Awards Businesswire
02-May-2023 NEUPATH HEALTH ANNOUNCES CLOSING OF PREVIOUSLY ANNOUNCED BROKERED OFFERING OF $1.453 MILLION OF SUBORDINATED AND POSTPONED UNSECURED NON-CONVERTIBLE DEBENTURES Businesswire
02-May-2023 Horizon Therapeutics plc Announces First Patient Enrolled in Phase 2 Trial Evaluating Daxdilimab for the Treatment of Lupus Nephritis Businesswire